Amphastar Announces Approval for Glucagon for Injection Kit, 1mg
The Pharma Data
DECEMBER 28, 2020
Food and Drug Administration (“FDA”) has approved its Abbreviated New Drug Application (“ANDA”) for Glucagon for Injection Emergency Kit, 1 mg. This further highlights Amphastar’s considerable abilities to bring complex generic drugs to the market, and more specifically, our strong peptide capabilities.”
52 
Let's personalize your content